REFERENCES
- Serruys PW, Luijten HE, Beatt KJ, Geuskens R, DeFeyter PJ, Van Den Brand M, Reiber JHC, Ten Katen HJ, Van Es GA, Hugenholt z PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circu-lation. 1988;77:361–371.
- Nobuyoshi M, Kumura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percuta-neous transluminal coronary angioplasty: pathologic ob- servations in 20 patients. J Am Coll Cardiol. 1991;17:433–439.
- Dilley RJ, McGeachie JK, Prendergas t FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Arch Surg. 1988;123:691–696.
- Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell prolifera-tion. J Am Coll Cardiol. 1990;15:1667–1687.
- LaMuraglia GM, ChandraSeka r NR, Flotte TJ, Abbott WM, Michaud N, Hasan T. Photodynami c therapy inhibition of experimental intimal hyperplasia: acute and chronic ef-fects. J Vasc Surg. 1994;19:321.
- Eton D, Colbur n MD, Shim V, Panek W, Lee D, Moore WS, Ahn SS. Inhibition of intimal hyperplasia by photodynami c therapy using Photofrin. J Surg Res. 1992;53:558.
- Dartsch PC, Ischinger T, Betz E. Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradia-tion: Implications for photodynamic therapy of vascular stenosis. J Am Coll Cardiol. 1990;15:1545.
- Dartsch PC, Ischinger T, Betz E. Differential effect of Photofrin II on growth of human smooth muscle cells from nonatherosclerotic arteries and atheromatous plaques in vitro. Arteriosclerosis. 1990;10:616.
- Hsiang YN, Houston GTM, Crespo MT, To E, Sobeh MS, Todd ME, Bower RD. Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe. Ann Vasc Surg. 1995;9:80–86.
- Hsiang YN, Crespo MT, Richter AM, Jain AK, Fragoso M, Levy J. In vitro and in vivo uptake of benzopor-phyrin derivative into human and miniswine atheroscle-rotic plaque. Photochem Photobiol. 1993;57:670.
- Manyak MJ, Russo A, Smith PD, Glatstein E. Photody- namic therapy. J Clin Oncol. 1988;6:380–391.
- Levy JG. Photodynamic therapy. TIBTECH 1995;13:14–17.
- Vincent GM, Fox J, Hill S. Benzoporphyrin derivative markedly inhibits smooth muscle/intimal proliferation in a restenosis model. Circulation. 1993;Supp l 88: I-657.
- Coats WD, Currier JW, Mejias Y, Narcisco HL, and Faxon DP. Tin ethyl etiopurpurin signifcantly inhibits smooth muscle cell proliferation in vivo. Biochem Cell Biol. 1996;74:325–331.
- Richter AM, Kelly B, Chow H, Lery JG. Preliminary stud-ies on more effective phototoxic agents than hematopor-phyrin. J Natl Cancer Inst. 1987;79:1327.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55.
- Chin AK, Monfort SY, Fogarty TJ. Balloon embolec-tomy catheter shear force gauge. Surg Gynecol Obstet. 1988;167:345.
- Pass HI. Photodynami c therapy in oncology: mechanisms and clinical use. JNCI. 1993;85:443–456.
- Vincent GM, Fox J, Jonhson S, Margaron P. Effects of benzoporphyrin derivative monoacid A on balloon-injured arteries in a swine model of restenosis. SPIE. 1996;2671:72–77.
- Hsiang YN, Todd ME, Bower RD. Determining light does for photodynamic therapy of atherosclerotic le-sions in the Yucatan miniswine. J Endovasc Surg. 1995;2: 365.
- Litvack F, Grundfest WS, Forrester JS, Fishbein MC, Swan HJC, Corday E, Rider DM, McDermid IS, Pacala TJ, Laudenslager JB. Effects of hematoporphyri n derivative and photodynamic therapy on atherosclerotic rabbits. Am J Cardiol. 1985;56:667–671.
- Vincent GM, Fox J, Charlton G, Hill JS, McClane R, Spikes JD. Presence of blood signifcantly decreases transmission of 630-nm laser light. Lasers Surg Med. 1991;11:399.